Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)

 

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate and support investigator-driven collaborative research to: 1) probe how vaccine elicited antibodies protect against viral acquisition via Fc receptor (FcR) mediated mechanisms; and 2) benchmark functional profiles of vaccines that protect against viral infections to inform advancement of HIV vaccine candidates. This initiative will support basic/pre-clinical research and analysis of clinical samples to evaluate parameters critical for the elicitation of protective FcR antibody effector function.

Active PA-14-218 Agency: Department of Health and Human Services
Office: National Institutes of Health Grant Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. 01/07/2017 This program does not have cost sharing or matching requirements. NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
http://grants.nih.gov/grants/guide/pa-files/PA-14-218.html FBOWebmaster@OD.NIH.GOV $0.00